Cargando…

Observation period for changes in proteinuria and risk prediction of end‐stage renal disease in general population

AIM: Proteinuria is known to be an independent risk factor of end‐stage renal disease (ESRD). But the associations between changes in dipstick proteinuria and the risk of ESRD in the general population and its appropriate observation period to predict incident ESRD are unknown. METHODS: We assessed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usui, Tomoko, Kanda, Eiichiro, Iseki, Chiho, Iseki, Kunitoshi, Kashihara, Naoki, Nangaku, Masaomi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120455/ https://www.ncbi.nlm.nih.gov/pubmed/28635004 http://dx.doi.org/10.1111/nep.13093

Ejemplares similares

Importance of glomerular filtration rate change as surrogate endpoint for the future incidence of end-stage renal disease in general Japanese population: community-based cohort study
por: Kanda, Eiichiro, et al.
Publicado: (2017)

eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database
por: Itano, Seiji, et al.
Publicado: (2023)

Cause-specific mortality in the general population with transient dipstick-proteinuria
por: Nagai, Kei, et al.
Publicado: (2019)

Trace proteinuria as a risk factor for cancer death in a general population
por: Matsui, Masaru, et al.
Publicado: (2021)

Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population
por: Nagai, Kei, et al.
Publicado: (2019)

Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012
por: Iseki, Kunitoshi
Publicado: (2013)

Nutrition and quality of life in chronic kidney disease patients: a practical approach for salt restriction
por: Iseki, Kunitoshi
Publicado: (2022)

Association of High Pulse Pressure With Proteinuria in Subjects With Diabetes, Prediabetes, or Normal Glucose Tolerance in a Large Japanese General Population Sample
por: Yano, Yuichiro, et al.
Publicado: (2012)

Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan
por: Nagai, Kei, et al.
Publicado: (2019)

Japanese society for dialysis therapy renal data registry—a window through which we can view the details of Japanese dialysis population
por: Hanafusa, Norio, et al.
Publicado: (2015)

A practical approach of salt and protein restriction for CKD patients in Japan
por: Iseki, Kunitoshi, et al.
Publicado: (2016)

New measures against chronic kidney diseases in Japan since 2018
por: Fukui, Akira, et al.
Publicado: (2019)

Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study
por: Ito, Sadayoshi, et al.
Publicado: (2021)

Sharing knowledge on dialysis registries worldwide
por: Iseki, Kunitoshi, et al.
Publicado: (2015)

Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar
por: Wen, Chi-Pang, et al.
Publicado: (2014)

Cardiovascular and Renal Outcomes Associated With Hyperkalemia in Chronic Kidney Disease: A Hospital-Based Cohort Study
por: Kohsaka, Shun, et al.
Publicado: (2021)

The role of oxidative stress and hypoxia in renal disease
por: Honda, Tomoko, et al.
Publicado: (2019)

Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort Study
por: Wakasugi, Minako, et al.
Publicado: (2017)

Weight Loss Improves Liver Dysfunction and Dipstick Proteinuria in Obesity: The Japan Specific Health Checkups Study
por: Nagai, Kei, et al.
Publicado: (2023)

Reduction in the magnitude of serum potassium elevation in combination therapy with esaxerenone (CS‐3150) and sodium–glucose cotransporter 2 inhibitor in patients with diabetic kidney disease: Subanalysis of two phase III studies
por: Shikata, Kenichi, et al.
Publicado: (2022)

The renoprotective effect of esaxerenone independent of blood pressure lowering: a post hoc mediation analysis of the ESAX-DN trial
por: Okuda, Yasuyuki, et al.
Publicado: (2022)

Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes
por: Oshima, Megumi, et al.
Publicado: (2018)

The combination of malnutrition-inflammation and functional status limitations is associated with mortality in hemodialysis patients
por: Kanda, Eiichiro, et al.
Publicado: (2021)

Routinely measured cardiac troponin I and N‐terminal pro‐B‐type natriuretic peptide as predictors of mortality in haemodialysis patients
por: Eriguchi, Masahiro, et al.
Publicado: (2022)

Summary of the 2018 ISN Frontiers Meeting: Kidney Disease and Cardiovascular Disease
por: Kume, Shinji, et al.
Publicado: (2018)

Impact of Metabolic Syndrome on the Mortality Rate among Participants in a Specific Health Check and Guidance Program in Japan
por: Iseki, Kunitoshi, et al.
Publicado: (2020)

Association of dialysis-related amyloidosis with lower quality of life in patients undergoing hemodialysis for more than 10 years: The Kyushu Dialysis-Related Amyloidosis Study
por: Tsuruya, Kazuhiko, et al.
Publicado: (2021)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic
por: Tsuboi, Nobuo, et al.
Publicado: (2021)

Machine-learning-based Web system for the prediction of chronic kidney disease progression and mortality
por: Kanda, Eiichiro, et al.
Publicado: (2023)

Correction: Proteinuria changes in kidney disease patients with clinical remission during the COVID-19 pandemic
por: Tsuboi, Nobuo, et al.
Publicado: (2021)

Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis
por: Kochi, Masako, et al.
Publicado: (2016)

Hyperkalemia in Real-World Patients Under Continuous Medical Care in Japan
por: Kashihara, Naoki, et al.
Publicado: (2019)

Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan
por: Kanda, Eiichiro, et al.
Publicado: (2020)

One-year change in plasma volume and mortality in the Japanese general population: An observational cohort study
por: Otaki, Yoichiro, et al.
Publicado: (2021)

Recent advances in renal regeneration
por: Hasegawa, Sho, et al.
Publicado: (2019)

Renal Hypoxia in CKD; Pathophysiology and Detecting Methods
por: Hirakawa, Yosuke, et al.
Publicado: (2017)

The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry
por: Maruyama, Yukio, et al.
Publicado: (2015)

Thresholds of iron markers for iron deficiency erythropoiesis—finding of the Japanese nationwide dialysis registry
por: Hamano, Takayuki, et al.
Publicado: (2015)

Long-term Weight Loss as a Predictor of Mortality in Hemodialysis Patients
por: Moromizato, Takuhiro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rbfce3t0c6ns2473cou6cncen2